Spanish scientists develop vaccine against Alzheimer’s

During a press conference, Dr. Ramon Cacabelos, project manager, presented the EB-101 Alzheimer vaccine along with scientific documentation which won the patent to manufacture it in the U.S., which already is negotiating with several multinational agencies to start human clinical...

U.S.A approves a reagent for the early diagnosis of Alzheimer’s

The Medical Products Agency of USA (FDA) has approved a reagent that can help to identify Alzheimer’s disease in the early stages. The radioactive product called flobetapir is designed to capture the characteristics of the disease, which would be visible by PET (positron...